Silo Pharma (SILO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Silo Pharma Inc. announced its 2024 pipeline prioritization focusing on mental health, chronic pain, and neurology through a press release issued on February 1, 2024.
For further insights into SILO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.